Compass Biotechnologies (OTCBB:COBI) reached up 13.63% in morning trading to $.25 with 500K shares traded. Compass Biotechnologies Inc. is focused on the commercialization of life-saving products targeted on the multi-billion dollar generic, biosimiliar and bio-better markets. Compass Biotechnologies announce the first product to be sourced from its manufacturing partner (PanGen of South Korea) will be a class of protein product known as Erythropoietins (EPO).
Repro-Med Systems, Inc., (PINK:REPR) reached up 13.38% in morning trading to $.394 with 240K shares traded. RMS Medical Products is the leading developer and FDA compliant manufacturer of portable medical devices for respiratory products and infusion therapy. RMS manufactures medical devices for a variety of markets including emergency-care, hospital, nursing home and home-care, that advance the quality of emergency care and treatment of chronic illnesses. The Company’s primary products are RES-Q-VAC and FREEDOM60. Repro-Med Systems, Inc., (REPR.PK) announced today that it has received approval from the Food and Drug Administration (FDA) to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo™ RMS Subcutaneous Needle Sets. The needle sets are intended for the delivery of medication to subcutaneous tissue. The needle sets have previously been approved and available for use by patients in Canada and Europe. Repro-Med Systems, Inc. utilizes the name RMS Medical Products.
Nuvilex, Inc. (PINK:NVLX) reached up 13.24% in morning trading to $.077 with 9M shares traded. Nuvilex is a Green Company believing in “Good for You, Good for the Environment” and are expanding their natural product lines and will be making important strides in the biotechnology arena. To that end, they have acquired a treatment technology designed to combat pancreatic cancer that has completed a Phase II clinical trial. Active biotechnology advances are already aggressively ongoing at Nuvilex and new biotechnology updates will be announced shortly. Current products include Cinnergen™, Cinnechol™, and Cinnsational™ to enhance a healthy lifestyle; Talsyn™ and NumaDerm™ for cosmetic use; Citroxin™ and Oraphyte™ as antimicrobial and antinematodal agents; Reme-Flu™, Legacy Biotechnologies’ flu combating regimen; and Virgin® and Infinitink®, heavy-metal-free tattoo inks. Nuvilex, Inc. (PINK SHEETS:NVLX.pk - News) announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this trial was recently acquired by Nuvilex.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
